The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ADVL1514, a phase 1 study of ABI-009 (nab-sirolimus) in pediatric patients with recurrent or refractory solid tumors, including CNS tumors as a single agent and in combination with temozolomide and irinotecan: A Children’s Oncology Group pediatric early-phase clinical trial network study.
 
Stuart Cramer
No Relationships to Disclose
 
Elizabeth Ann Gilger
No Relationships to Disclose
 
Susan Burlingame
No Relationships to Disclose
 
Olga Militano
No Relationships to Disclose
 
Xiaowei Liu
No Relationships to Disclose
 
Charles G. Minard
Other Relationship - CHEST Journal
 
Alyssa Terry Reddy
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Novartis
 
Stephan D. Voss
No Relationships to Disclose
 
Stacey L. Berg
Other Relationship - Children's Oncology Group; Pediatric Early Phase Clincial Trials Network
 
Joel M. Reid
No Relationships to Disclose
 
Elizabeth Fox
No Relationships to Disclose
 
Brenda Weigel
No Relationships to Disclose